US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Lakewood-Amedex Biotherapeutics (Direct Listing)

2.13

-0.1100-4.91%

Post-market: 2.130.00000.00%16:22 EDT

Volume:38.84K

Turnover:84.46K

Market Cap:5.05M

PE:-0.21

High:2.29

Open:2.20

Low:2.10

Close:2.24

52wk High:98.20

52wk Low:1.66

Shares:2.37M

Float Shares:1.42M

Volume Ratio:0.52

T/O Rate:2.74%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-10.2000

EPS(LYR):-8.3987

ROE:-402.84%

ROA:-139.40%

PB:1.17

PE(LYR):-0.25

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Lakewood-Amedex Biotherapeutics (Direct Listing)

Exchange:

NASDAQ

Establishment Date:

2006

Employees:

- -

Office Location:

8031 Cooper Creek Blvd.,Suite 103,University Park,Florida,United States

Website:

http://lakewoodamedex.com

Zip Code:

34201

Phone:

Fax:

- -

Introduction:

Lakewood-Amedex Biotherapeutics Inc. was originally incorporated in Delaware on July 11, 2006. The company is a private pharmaceutical firm focused on addressing the global health crisis of antimicrobial resistance (AMR) through the development of its bisphosphoramide class of antibacterial agents. Its approach involves a novel mechanism designed to rapidly destabilize bacterial membranes, potentially reducing the likelihood of resistance development. The lead compound, Nu-3, is currently in clinical trials for treating infected diabetic foot ulcers as a topical gel providing rapid antibacterial action and targeted delivery, with additional applications being explored for complicated urinary tract infections and pulmonary infections.

Directors

Name

Position

Doug Manion

Chairman of the Board and Independent Director

Kelvin Cooper

Chief Executive Officer,Director and SVP Research & Development

Joseph Tucker

Independent Director

Leonard J. DeRoma

Independent Director

Shareholders

Name

Position

Kelvin Cooper

Chief Executive Officer,Director and SVP Research & Development

Peter Ceccacci

Chief Financial Officer and VP Administration

Thomas Balzer

Chief Medical Officer and SVP Clinical Development

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/LABT/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABT\",,,,,undefined,":{"symbol":"LABT","market":"US","secType":"STK","nameCN":"Lakewood-Amedex Biotherapeutics (Direct Listing)","latestPrice":2.13,"timestamp":1787601600000,"preClose":2.24,"halted":0,"volume":38838,"hourTrading":{"tag":"盘后","latestPrice":2.13,"preClose":2.13,"latestTime":"16:22 EDT","volume":1774,"amount":3901.0355796,"timestamp":1787602927210,"change":0,"changeRate":0,"amplitude":0.079812},"delay":0,"changeRate":-0.049107142857142995,"floatShares":1415552,"shares":2369700,"eps":-10.199959,"marketStatus":"Post-Mkt","change":-0.11,"latestTime":"08-24 16:28:24 EDT","open":2.2,"high":2.29,"low":2.1,"amount":84460.7966424,"amplitude":0.084821,"askPrice":2.25,"askSize":50,"bidPrice":2.12,"bidSize":49,"shortable":3,"etf":0,"ttmEps":-10.199959,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787616000000},"marketStatusCode":4,"adr":0,"listingDate":1776916800000,"exchange":"NASDAQ","adjPreClose":2.24,"preHourTrading":{"tag":"盘前","latestPrice":2.2,"preClose":2.24,"latestTime":"09:28 EDT","volume":1059,"amount":2400.443772,"timestamp":1787578082120,"change":-0.04,"changeRate":-0.017857,"amplitude":0.093616},"postHourTrading":{"tag":"盘后","latestPrice":2.13,"preClose":2.13,"latestTime":"16:22 EDT","volume":1774,"amount":3901.0355796,"timestamp":1787602927210,"change":0,"changeRate":0,"amplitude":0.079812},"volumeRatio":0.523085},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABT\",,,,,undefined,":{"symbol":"LABT","floatShares":1415552,"roa":"-139.40%","roe":"-402.84%","lyrEps":-8.39872,"volumeRatio":0.523085,"shares":2369700,"dividePrice":0,"high":2.29,"amplitude":0.084821,"preClose":2.24,"low":2.1,"week52Low":1.66,"pbRate":"1.17","week52High":98.2,"institutionHeld":0,"latestPrice":2.13,"committee":-0.010101,"eps":-10.199959,"divideRate":0,"volume":38838,"delay":0,"ttmEps":-10.199959,"open":2.2,"prevYearClose":80,"prevWeekClose":2.24,"prevMonthClose":2.02,"prevQuarterClose":3.14,"fiveDayClose":2.16,"twentyDayClose":2.5,"sixtyDayClose":7.299},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-06-22","symbol":"LABT","defaultRemindTime":1782135000000,"type":"split","dateTimestamp":1782100800000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABT\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LABT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LABT","date":"2026-08-21","current":-0.208824,"percent":0.905405,"low":-12.282138,"twenty":-2.806803,"median":-1.276597,"eighty":-0.779084,"high":-0.62611,"avg":-2.731171,"sd":3.316371,"marketCap":5189616},"quantilePoints":[{"date":"2026-05-08","current":-12.282138,"twenty":-12.192813,"median":-11.891342,"eighty":-11.604759,"marketCap":47257207},{"date":"2026-05-15","current":-7.294845,"twenty":-12.043939,"median":-11.649421,"eighty":-11.314454,"marketCap":28067917},{"date":"2026-05-22","current":-2.865088,"twenty":-11.850402,"median":-11.258627,"eighty":-3.412052,"marketCap":11023817},{"date":"2026-05-29","current":-2.716586,"twenty":-11.716415,"median":-6.438817,"eighty":-2.758568,"marketCap":10452435},{"date":"2026-06-05","current":-2.512255,"twenty":-11.604759,"median":-3.225364,"eighty":-2.559299,"marketCap":9666247},{"date":"2026-06-12","current":-2.69016,"twenty":-11.537766,"median":-2.813168,"eighty":-2.512255,"marketCap":10350760},{"date":"2026-06-18","current":-2.241304,"twenty":-11.42611,"median":-2.776507,"eighty":-2.512255,"marketCap":8623724},{"date":"2026-06-26","current":-1.276597,"twenty":-10.242559,"median":-2.72924,"eighty":-2.388094,"marketCap":4911883},{"date":"2026-07-02","current":-1.116845,"twenty":-7.294845,"median":-2.69016,"eighty":-1.477578,"marketCap":4725718},{"date":"2026-07-10","current":-0.893476,"twenty":-5.58279,"median":-2.580737,"eighty":-1.276597,"marketCap":3780575},{"date":"2026-07-17","current":-0.62611,"twenty":-3.536511,"median":-2.512255,"eighty":-1.062695,"marketCap":2649266},{"date":"2026-07-24","current":-1.03562,"twenty":-3.225364,"median":-2.41344,"eighty":-0.92732,"marketCap":4382030},{"date":"2026-07-31","current":-0.653185,"twenty":-2.937143,"median":-2.34533,"eighty":-0.879262,"marketCap":2763829},{"date":"2026-08-07","current":-0.754716,"twenty":-2.857942,"median":-1.477578,"eighty":-0.80819,"marketCap":3193440},{"date":"2026-08-14","current":-0.78856,"twenty":-2.830251,"median":-1.371504,"eighty":-0.793975,"marketCap":3336643},{"date":"2026-08-21","current":-0.706322,"twenty":-2.806803,"median":-1.276597,"eighty":-0.779084,"marketCap":5189616}],"updateTime":1787597693102},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1977810588,"yearFounded":2006,"address":"8031 Cooper Creek Blvd.,Suite 103,University Park,Florida,United States","zipCode":"34201","officePhone":"941 225 2515","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://lakewoodamedex.com","stockEarnings":[{"period":"1week","weight":-0.0132},{"period":"1month","weight":-0.3431},{"period":"3month","weight":-0.683},{"period":"6month","weight":-0.972},{"period":"ytd","weight":-0.972}],"compareEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":0.0245},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.1107},{"period":"1year","weight":0.2048},{"period":"ytd","weight":0.1229}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Lakewood-Amedex Biotherapeutics Inc. was originally incorporated in Delaware on July 11, 2006. The company is a private pharmaceutical firm focused on addressing the global health crisis of antimicrobial resistance (AMR) through the development of its bisphosphoramide class of antibacterial agents. Its approach involves a novel mechanism designed to rapidly destabilize bacterial membranes, potentially reducing the likelihood of resistance development. The lead compound, Nu-3, is currently in clinical trials for treating infected diabetic foot ulcers as a topical gel providing rapid antibacterial action and targeted delivery, with additional applications being explored for complicated urinary tract infections and pulmonary infections.","exchange":"NASDAQ","name":"Lakewood-Amedex Biotherapeutics (Direct Listing)","nameEN":"Lakewood-Amedex Biotherapeutics (Direct Listing)"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"LABT\",market:\"US\",,,undefined,":{"directors":[{"name":"Doug Manion","position":"Chairman of the Board and Independent Director"},{"name":"Kelvin Cooper","position":"Chief Executive Officer,Director and SVP Research & Development"},{"name":"Joseph Tucker","position":"Independent Director"},{"name":"Leonard J. DeRoma","position":"Independent Director"}],"executives":[{"name":"Kelvin Cooper","position":"Chief Executive Officer,Director and SVP Research & Development"},{"name":"Peter Ceccacci","position":"Chief Financial Officer and VP Administration"},{"name":"Thomas Balzer","position":"Chief Medical Officer and SVP Clinical Development"}]}}}